tiprankstipranks
GeneTether Therapeutics, Inc. (TSE:GTTX)
:GTTX
Canadian Market

GeneTether Therapeutics, Inc. (GTTX) Income Statement

Compare
3 Followers

GeneTether Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), GeneTether Therapeutics, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q3, GeneTether Therapeutics, Inc.'s net income was $-128.73K. See GeneTether Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―
EBITDA
$ -688.36K$ -1.72M$ -1.64M$ -71.96K
Operating Income
$ -747.28K$ -1.72M$ -1.64M$ -71.96K
Other Income/Expenses
$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―
Net Income
$ -688.36K$ -1.72M$ -1.64M$ -72.97K
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

GeneTether Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis